Jennifer Jarrett

Filings by Jennifer Jarrett span 5 companies, the busiest being Arcus Biosciences, Inc., Syndax Pharmaceuticals Inc and Arena Pharmaceuticals Inc. Between 4 June 2021 and 25 September 2026, the trades on record add up to 44 filings.

Market trades split into 1 purchase (€222k) and 22 sales (€5.4M). Netting one side against the other leaves €5.1M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 16 share grants and 2 option exercises. 2026 to date brings 1 purchase and no sales.

The newest entry dates from 28 September 2026: an open-market purchase of €222k, in Damora Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.